.. Généralités-sur-l-'allogreffe and .. Le-greffon, 27 I) Historique de la greffe de cellules souches hématopoïétiques27 II) Déroulement de l28 A), p.29

L. and .. Eff, 29 C) La prise du greffon31 IV) Résultats de l'allogreffe31 A)31 A.1) Les antigènes mineurs d'histocompatibilités, .32 A.3) Les lymphocytes Natural Killer, p.32

.. Le-rejet-du-greffon, 35 E) Les complications principales, p.36

.. Immunité-en-post-allogreffe, 47 F.1) Reconstitution immunitaire, 47 F.2) Les infections en post, p.48

I. Composition-du-greffon and .. , 50 A) Cellules nucléées totales50 B) Cellules souches hématopoïétiques, 50 B.2) Les cellules souches hématopoïétiques, p.52

I. La-prise-de-la-greffe, .. La-niche-hématopoïétique, and .. , 59 A)59 B) Les étapes de la reprise de l'hématopoïèse après la greffe, 60 C) Les manipulations du, p.60

I. Choix-du-donneur, .. Compatibilité, and H. , 68 II)68 A), .68 C) Choix du type de greffon : moelle versus CSP, p.68

I. Conditionnement, G. Prévention-de-la, .. Traitements-de-support, and G. Prophylaxie-de-la, 68 A)69 C) Les prophylaxies anti-infectieuses, ., vol.68, p.69

.. Recueil-du-greffon,-manipulation-du-greffon-et-contrôle-qualité, 69 A) Prélèvement médullaire au bloc opératoire69 B) Manipulation sur le greffon, Désérythrocytation, p.70

.. Définition-des-points-clefs-post-greffe, 73 A) Reconstitution hématopoïétique73 B)73 C) Erreur ! Signet non défini. E) MVO, MAT, syndrome de fuite capillaire et syndrome de prise de greffe, .74 G) La mortalité liée à la greffe, p.74

I. Description-de-la-population and .. , 76 II) Description du greffon79 A) Composition79 B) Impact des caractéristiques pré-greffe sur la composition du greffon, .80 D) Lien entre les différents types de cellules, p.83

L. Devenir-de, 84 A)84 B) Reconstitution hématopoïétique, 88 B.4) Patients avec la reconstitution en PNN et en plaquettes la plus lente, p.90

I. Impact-des-manipulations and .. , 118 III) Impact du conditionnement, IV), p.119

C. Pour-les, 015x10 8 /kg CNT, on observe significativement (p=0.0307) plus d'infection bactérienne Pour les CD34+, en cas de greffon comportant moins de 1.93x10 6 /kg ou moins de 3.47x10 6 /kg on observe significativement (p=0.0169 et p=0.0475 respectivement) plus d'infection bactérienne. Pour les CFU-GM, en cas de greffon comportant moins de 53

B. Dw, C. Mj, L. Jf, and N. Fe, Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication, Br Med J. 15 sept, vol.2, issue.4993, pp.626-627, 1956.

T. Ed, L. Hl-jr, L. Wc, and F. Jw, Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy, N Engl J Med. 12 sept, vol.257, issue.11, pp.491-496, 1957.

G. Mathé, J. Amiel, L. Schwarzenberg, A. Cattan, and M. Schneider, Adoptive immunotherapy of acute leukemia: experimental and clinical results, Cancer Res. oct, vol.25, issue.9, pp.1525-1531, 1965.

E. Gluckman, H. Broxmeyer, A. Auerbach, H. Friedman, G. Douglas et al., Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling, New England Journal of Medicine, vol.321, issue.17, pp.1174-1178, 1989.
DOI : 10.1056/NEJM198910263211707

P. Mcsweeney, D. Niederwieser, J. Shizuru, B. Sandmaier, A. Molina et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, vol.97, issue.11, pp.3390-3400, 2001.
DOI : 10.1182/blood.V97.11.3390

C. Anasetti, B. Logan, S. Lee, E. Waller, D. Weisdorf et al., Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors, New England Journal of Medicine, vol.367, issue.16, pp.1487-1496, 2012.
DOI : 10.1056/NEJMoa1203517

URL : http://europepmc.org/articles/pmc3816375?pdf=render

A. Bacigalupo, A. Dominietto, T. Di-grazia, F. Lamperelli, A. Gualandi et al., Unmanipulated haploidentical transplants compared with other alterntive donors and matched sibling graft : a single centre experience in 488 patients

A. Kassim, W. Chinratanalab, J. Ferrara, and S. Mineishi, Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: ???what is the best recipe????, Bone Marrow Transplantation, vol.101, issue.Suppl. 1, pp.565-574, 2005.
DOI : 10.1182/blood-2002-05-1340

M. Horowitz, R. Gale, P. Sondel, J. Goldman, J. Kersey et al., Graft-versusleukemia reactions after bone marrow transplantation, Blood. 1 févr, vol.75, issue.3, pp.555-562, 1990.

A. Dickinson, X. Wang, L. Sviland, F. Vyth-dreese, G. Jackson et al., In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens, Nature Medicine, vol.6, issue.4, pp.410-414, 2002.
DOI : 10.1038/79573

A. Filipovich, D. Weisdorf, S. Pavletic, G. Socie, J. Wingard et al., National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report, Biology of Blood and Marrow Transplantation, vol.11, issue.12, pp.945-956, 2005.
DOI : 10.1016/j.bbmt.2005.09.004

J. Ferrara, K. Cooke, L. Pan, and W. Krenger, The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease, Stem Cells, vol.86, issue.5, pp.473-489, 1996.
DOI : 10.7326/0003-4819-89-6-893

J. Ferrara and P. Reddy, Pathophysiology of Graft-Versus-Host Disease, Seminars in Hematology, vol.43, issue.1, pp.3-10, 2006.
DOI : 10.1053/j.seminhematol.2005.09.001

R. Sackstein, A Revision of Billingham???s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.2-8, 2006.
DOI : 10.1016/j.bbmt.2005.09.015

H. Glucksberg, R. Storb, A. Fefer, C. Buckner, P. Neiman et al., CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S, Transplantation, vol.18, issue.4, pp.295-304, 1974.
DOI : 10.1097/00007890-197410000-00001

P. Martin, J. Rizzo, J. Wingard, K. Ballen, P. Curtin et al., First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation, vol.18, issue.8, pp.1150-1163, 2012.
DOI : 10.1016/j.bbmt.2012.04.005

P. Martin, Biology of Chronic Graft-versus-Host Disease: Implications for a Future Therapeutic Approach, The Keio Journal of Medicine, vol.57, issue.4, pp.177-183, 2008.
DOI : 10.2302/kjm.57.177

Y. Chu and R. Gress, Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues, Biology of Blood and Marrow Transplantation, vol.14, issue.4, pp.365-378, 2008.
DOI : 10.1016/j.bbmt.2007.12.002

A. Bergeron, S. Feuillet, V. Meignin, G. Socie, and A. Tazi, Les complications pulmonaires tardives non infectieuses apr??s allogreffe de cellules souches h??matopo????tiques, Revue des Maladies Respiratoires, vol.25, issue.2, pp.173-183, 2008.
DOI : 10.1016/S0761-8425(08)71515-8

H. Shulman, K. Sullivan, P. Weiden, G. Mcdonald, G. Striker et al., Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20

D. Wolff, A. Gerbitz, F. Ayuk, A. Kiani, G. Hildebrandt et al., Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD, Biology of Blood and Marrow Transplantation, vol.16, issue.12, pp.1611-1628, 2010.
DOI : 10.1016/j.bbmt.2010.06.015

D. Wolff, M. Schleuning, S. Von-harsdorf, U. Bacher, A. Gerbitz et al., Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.17, issue.1, pp.1-17, 2011.
DOI : 10.1016/j.bbmt.2010.05.011

J. Pérez-simón, C. Encinas, F. Silva, M. Arcos, M. Díez-campelo et al., Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy, Biology of Blood and Marrow Transplantation, vol.14, issue.10, pp.1163-1171, 2008.
DOI : 10.1016/j.bbmt.2008.07.015

R. Peffault-de-latour, A. Xhaard, V. Fremeaux-bacchi, P. Coppo, A. Fischer et al., Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy, British Journal of Haematology, vol.118, issue.2, pp.279-280, 2013.
DOI : 10.1182/blood-2011-02-321315

J. Auletta and H. Lazarus, Immune restoration following hematopoietic stem cell transplantation: an evolving target, Bone Marrow Transplantation, vol.103, issue.Suppl. 1, pp.835-857, 2005.
DOI : 10.1182/blood-2003-11-4041

URL : http://www.nature.com/bmt/journal/v35/n9/pdf/1704966a.pdf

N. Dulphy, P. Haas, M. Busson, S. Belhadj, P. De-latour et al., An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation, J Immunol Baltim Md août, vol.181, issue.13, pp.2227-2237, 1950.

D. Zlotoff, S. Zhang, D. Obaldia, M. Hess, P. Todd et al., Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation, Blood, vol.118, issue.7, 2011.
DOI : 10.1182/blood-2010-12-324954

K. Weinberg, B. Blazar, J. Wagner, E. Agura, B. Hill et al., Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation, Blood, vol.97, issue.5, pp.1458-1466, 2001.
DOI : 10.1182/blood.V97.5.1458

URL : http://www.bloodjournal.org/content/bloodjournal/97/5/1458.full.pdf

A. Gratwohl, R. Brand, F. Frassoni, V. Rocha, D. Niederwieser et al., Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time, Bone Marrow Transplantation, vol.100, issue.Suppl 2, pp.757-769, 2005.
DOI : 10.1182/blood-2002-03-0801

M. Tomblyn, T. Chiller, H. Einsele, R. Gress, K. Sepkowitz et al., Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, vol.15, issue.10, pp.1143-1238, 2009.
DOI : 10.1016/j.bbmt.2009.06.019

I. Godin, J. Garcia-porrero, A. Coutinho, F. Dieterlen-lièvre, and M. Marcos, Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors, Nature, vol.364, issue.6432, pp.67-70, 1993.
DOI : 10.1038/364067a0

M. Tavian, K. Biasch, L. Sinka, J. Vallet, and B. Péault, Embryonic origin of human hematopoiesis, The International Journal of Developmental Biology, vol.54, issue.6-7, pp.6-71061, 2010.
DOI : 10.1387/ijdb.103097mt

M. Tavian, F. Cortés, P. Charbord, M. Labastie, and B. Péault, Emergence of the haematopoietic system in the human embryo and foetus, Haematologica. juin, vol.84, 1999.

B. Aj, E. Mcculloch, and T. Je, Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells, Nature. 2 févr, vol.197, pp.452-454, 1963.

J. Lewis, M. Passovoy, M. Freeman, F. Trobaugh, and . Jr, The repopulating potential and differentiation capacity of hematopoietic stem cells from the blood and bone marrow of normal mice, Journal of Cellular Physiology, vol.150, issue.2, pp.121-132, 1968.
DOI : 10.3181/00379727-103-25470

M. Ea and T. Je, The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice, Radiat Res. juill, vol.13, pp.115-125, 1960.

L. Purton and D. Scadden, Limiting Factors in Murine Hematopoietic Stem Cell Assays, Cell Stem Cell, vol.1, issue.3, pp.263-270, 2007.
DOI : 10.1016/j.stem.2007.08.016

G. Spangrude, S. Heimfeld, and I. Weissman, Purification and characterization of mouse hematopoietic stem cells, Science, vol.241, issue.4861, pp.58-62, 1988.
DOI : 10.1126/science.2898810

N. Uchida and I. Weissman, Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow, Journal of Experimental Medicine, vol.175, issue.1, pp.175-184, 1992.
DOI : 10.1084/jem.175.1.175

K. Ikuta and I. Weissman, Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation., Proceedings of the National Academy of Sciences, vol.89, issue.4, pp.1502-1506, 1992.
DOI : 10.1073/pnas.89.4.1502

M. Osawa, K. Hanada, H. Hamada, and H. Nakauchi, Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell, Science, vol.273, issue.5272, pp.242-245, 1996.
DOI : 10.1126/science.273.5272.242

M. Goodell, K. Brose, G. Paradis, A. Conner, and R. Mulligan, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, Journal of Experimental Medicine, vol.183, issue.4, pp.1797-1806, 1996.
DOI : 10.1084/jem.183.4.1797

C. Civin, L. Strauss, C. Brovall, M. Fackler, J. Schwartz et al., Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells, J Immunol Baltim Md juill, vol.133, issue.1, pp.157-165, 1950.

C. Civin, CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009, Transfusion, vol.180, issue.1, pp.2046-2056, 2009.
DOI : 10.4049/jimmunol.180.8.5645

L. Rusten, S. Jacobsen, O. Kaalhus, O. Veiby, S. Funderud et al., Functional differences between CD38-and DR-subfractions of CD34+ bone marrow cells, Blood. 1 sept, vol.84, issue.5, pp.1473-1481, 1994.

D. Krause, M. Fackler, C. Civin, and W. May, CD34: structure, biology, and clinical utility, Blood. 1 janv, vol.87, issue.1, pp.1-13, 1996.

M. Fackler, D. Krause, O. Smith, C. Civin, and W. May, Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells, Blood. 1 juin, vol.85, issue.11, pp.3040-3047, 1995.

D. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-yee, The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-226, 1996.
DOI : 10.1089/scd.1.1996.5.213

Y. Shiozawa, A. Havens, K. Pienta, and R. Taichman, The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells and unwitting host to molecular parasites, Leukemia, vol.21, issue.5, pp.941-950, 2008.
DOI : 10.3181/00379727-140-36426

A. Wilson and A. Trumpp, Bone-marrow haematopoietic-stem-cell niches, Nature Reviews Immunology, vol.89, issue.2, pp.93-106, 2006.
DOI : 10.1038/nature04247

L. Petz, Immunohematologic Problems Associated With Bone Marrow Transplantation, Transfusion Medicine Reviews, vol.1, issue.2, pp.85-100, 1987.
DOI : 10.1016/S0887-7963(87)70009-1

H. Braine, L. Sensenbrenner, S. Wright, P. Tutschka, R. Saral et al., Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion, Blood. août, vol.60, issue.2, pp.420-425, 1982.

N. Collins, A. Gee, A. Durett, F. Kan, M. Zhang et al., The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes, Biology of Blood and Marrow Transplantation, vol.16, issue.2, pp.253-262, 2010.
DOI : 10.1016/j.bbmt.2009.10.004

C. Faucher, L. Corroller, A. Chabannon, C. Viens, P. Stoppa et al., Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery, Journal of Hematotherapy, vol.5, issue.6, pp.663-670, 1996.
DOI : 10.1089/scd.1.1996.5.663

C. Weaver, B. Hazelton, R. Birch, P. Palmer, C. Allen et al., An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy, Blood. 15 nov, vol.86, issue.10, pp.3961-3969, 1995.

M. Dercksen, S. Rodenhuis, M. Dirkson, W. Schaasberg, J. Baars et al., Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation., Journal of Clinical Oncology, vol.13, issue.8, pp.1922-1932, 1995.
DOI : 10.1200/JCO.1995.13.8.1922

F. Lanza, D. Campioni, A. Hellmann, G. Milone, A. Wahlin et al., Individual Quality Assessment Of Autografting By Probability Estimation For Clinical End-Points: A Prospective Validation Study Of The European Blood And Marrow Transplantation (Ebmt), Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 2013.

N. Gorin, M. Labopin, J. Reiffers, N. Milpied, D. Blaise et al., Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission, Blood, vol.116, issue.17, pp.3157-3162, 2010.
DOI : 10.1182/blood-2009-11-252197

A. Gianni, Where do we stand with respect to the use of peripheral blood progenitor cells?, Annals of Oncology, vol.5, issue.9, pp.781-784, 1994.
DOI : 10.1093/oxfordjournals.annonc.a059003

S. Siena, R. Schiavo, P. Pedrazzoli, and C. Carlo-stella, Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy, Journal of Clinical Oncology, vol.18, issue.6, pp.1360-1377, 2000.
DOI : 10.1200/JCO.2000.18.6.1360

R. Storb, R. Prentice, and E. Thomas, Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival., Journal of Clinical Investigation, vol.59, issue.4, pp.625-632, 1977.
DOI : 10.1172/JCI108680

J. Sierra, B. Storer, J. Hansen, J. Bjerke, P. Martin et al., Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose, Blood. 1 juin, vol.89, issue.11, pp.4226-4235, 1997.

A. Dominietto, T. Lamparelli, A. Raiola, M. Van-lint, F. Gualandi et al., Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation, Blood, vol.100, issue.12, pp.3930-3934, 2002.
DOI : 10.1182/blood-2002-01-0339

M. Mohty, K. Bilger, E. Jourdan, M. Kuentz, M. Michallet et al., Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation, Leukemia, vol.75, issue.5, pp.869-875, 2003.
DOI : 10.1056/NEJM198106183042507

A. Urbano-ispizua, E. Carreras, P. Marín, M. Rovira, C. Martínez et al., Allogeneic transplantation of CD34+ selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34+ cells?, Blood, vol.98, issue.8, pp.2352-2357, 2001.
DOI : 10.1182/blood.V98.8.2352

D. Mavroudis, E. Read, M. Cottler-fox, D. Couriel, J. Molldrem et al., CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies, Blood. 15 oct, vol.88, issue.8, pp.3223-3229, 1996.

R. Morariu-zamfir, V. Rocha, A. Devergie, G. Socié, P. Ribaud et al., Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia, Bone Marrow Transplantation, vol.95, issue.6, pp.575-580, 2001.
DOI : 10.1200/JCO.2000.18.3.537

H. Bittencourt, V. Rocha, S. Chevret, G. Socié, H. Espérou et al., Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation, Blood, vol.99, issue.8, pp.2726-2733, 2002.
DOI : 10.1182/blood.V99.8.2726

N. Russell, A. Hunter, S. Rogers, J. Hanley, and D. Anderson, Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation, The Lancet, vol.341, issue.8858, p.1482, 1993.
DOI : 10.1016/0140-6736(93)90929-B

H. Bittencourt, V. Rocha, S. Chevret, G. Socié, H. Espérou et al., Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation, Blood, vol.99, issue.8, pp.2726-2733, 2002.
DOI : 10.1182/blood.V99.8.2726

F. Geneviève, A. Godon, A. Marteau-tessier, and M. Zandecki, Automated hematology analysers and spurious counts Part 2. Leukocyte count and differential], Ann Biol Clin avr, vol.70, issue.2, pp.141-154, 2012.

J. Piedras-ross, E. León-rodríguez, S. Sánchez-guerrero, and X. López-karpovitch, Comparison of Single- and Dual-Platform Approaches to Enumerate CD34+ Cells in Bone Marrow and Mobilized Peripheral Blood Stem Cells, Archives of Medical Research, vol.34, issue.1, pp.16-19, 2003.
DOI : 10.1016/S0188-4409(02)00451-4

J. Gratama, E. Braakman, J. Kraan, P. Lankheet, W. Levering et al., Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration, Clinical and Laboratory Haematology, vol.21, issue.5, pp.337-346, 1999.
DOI : 10.1046/j.1365-2257.1999.00236.x

F. Moscardó, A. Urbano-ispizua, G. Sanz, S. Brunet, D. Caballero et al., Positive selection for CD34 + reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation, Experimental Hematology, vol.31, issue.6, pp.545-550, 2003.
DOI : 10.1016/S0301-472X(03)00070-5

J. Larghero, D. Rea, H. Esperou, N. Biscay, M. Maurer et al., ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery, Transfusion, vol.45, issue.3, pp.398-402, 2006.
DOI : 10.1046/j.1537-2995.2003.00465.x

S. Rowley, P. Liang, and L. Ulz, Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components, Bone Marrow Transplantation, vol.141, issue.7, pp.749-757, 2000.
DOI : 10.1111/j.1600-0609.1986.tb01763.x

C. Anasetti, B. Logan, and D. Confer, Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood versus bone marrow stem cells, N Engl J Med. 17 janv, vol.368, issue.3, p.288, 2013.